June 8 (UPI) -- Researchers at the University of California Los Angeles have created a molecular compound that improves balance and coordination in mice with Parkinson's disease.
The drug, CLR01, reduced the level of toxic protein in the brain that is believed to be responsible for the development of Parkinson's disease.